ClinicalTrials.gov
public full text
Public Domain
A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults
To evaluate the efficacy of GWP42003-P as adjunctive treatment in reducing the number of drop seizures when compared with placebo, in participants with Lennox-Gastaut Syndrome (LGS).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Cannabidiol (CBD) and Pediatric Epilepsy#813100
- Cannabis for Spasticity in Multiple Sclerosis#898260
- MIVetsCan: Cannabidiol (CBD)-Care Trial#1031331
- Repeated CBD Administration and Cannabis Outcomes#1045133
- Cannabidiol reduces atypical absence seizures and epileptic spasms in a Gabrb3(+/D120N) mouse model of Lennox-Gastaut syndrome.#395928
Record · ID 1140749
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive